Arkolith/Insider Trading/AARD/Form 4

Sun Nelson

Chief Financial OfficerAardvark Therapeutics, Inc. (AARD) · full profile →Form 4 · filed Feb 19, 2025
Net Buying
Open-Market Buys
$160K
Open-Market Sells
$0
Net Open-Market Flow
$160K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 14, 2025Buy(P)10K$16.00$160K99K
Feb 14, 2025Conversion(C)7K——89K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 14, 2025Conversion(C)59K—$00

Transaction Codes

P
Open-market purchase
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-023243) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML